Mobile Phone App Determines Risk of Preterm Birth
|
By HospiMedica International staff writers Posted on 09 Mar 2020 |

Image: The QUiPP v2 app can calculate pre-term birth risk (Photo courtesy of GeneticApps)
A user-friendly mobile phone application will allow doctors to quickly calculate a woman's individual risk of preterm birth, claims a new study.
Developed by researchers at King’s College London (KCL; United Kingdom), QUiPP v2 calculates spontaneous preterm birth (sPTB) risk based on a woman's individual risk factors, such as previous preterm birth, late miscarriage, or symptoms, along with clinical test results that help to predict preterm birth, such as cervical length (CL), quantitative fetal fibronectin (qfFN) or both tests combined, and taking into account further risk factors, such as multiple pregnancy. The app then produces a simple individual percentage risk score.
To test the app, the researchers conducted a prospective secondary analysis of data of asymptomatic women at high risk of sPTB recruited in 13 UK preterm birth clinics. In all, 1,803 women (3,878 visits) were included in the training set, and 904 women (1,400 visits) in the validation set. The results revealed that QUiPP v2 showed high accuracy for the prediction of sPTB at < 30, < 34 and < 37 weeks' gestation, and within one, two, and four weeks of testing. The study was published in the March 2020 issue of Ultrasound in Obstetrics and Gynecology.
“We are delighted to be able to share the findings of our work, which shows that the QUiPP app is very reliable in predicting preterm birth in women at risk,” said lead author Jenny Carter, MD, of the KCL department of Women & Children's Health. “This should mean that women who need treatments are offered them appropriately, and also that doctors and women can be reassured when these treatments are not needed, which reduces the possibility of negative effects and unnecessary costs for the NHS.”
Preterm birth refers to the birth of a baby of less than 37 weeks gestational age, before the developing organs are mature enough to allow normal postnatal survival. The cause for preterm birth is in many situations elusive and unknown; many factors appear to be associated with the development of preterm birth, making the reduction of preterm birth a challenging proposition. Premature infants are at greater risk for short and long term complications, including disabilities and impediments in growth and mental development. Preterm birth is the major cause of neonatal mortality in developed countries.
Related Links:
King’s College London
Developed by researchers at King’s College London (KCL; United Kingdom), QUiPP v2 calculates spontaneous preterm birth (sPTB) risk based on a woman's individual risk factors, such as previous preterm birth, late miscarriage, or symptoms, along with clinical test results that help to predict preterm birth, such as cervical length (CL), quantitative fetal fibronectin (qfFN) or both tests combined, and taking into account further risk factors, such as multiple pregnancy. The app then produces a simple individual percentage risk score.
To test the app, the researchers conducted a prospective secondary analysis of data of asymptomatic women at high risk of sPTB recruited in 13 UK preterm birth clinics. In all, 1,803 women (3,878 visits) were included in the training set, and 904 women (1,400 visits) in the validation set. The results revealed that QUiPP v2 showed high accuracy for the prediction of sPTB at < 30, < 34 and < 37 weeks' gestation, and within one, two, and four weeks of testing. The study was published in the March 2020 issue of Ultrasound in Obstetrics and Gynecology.
“We are delighted to be able to share the findings of our work, which shows that the QUiPP app is very reliable in predicting preterm birth in women at risk,” said lead author Jenny Carter, MD, of the KCL department of Women & Children's Health. “This should mean that women who need treatments are offered them appropriately, and also that doctors and women can be reassured when these treatments are not needed, which reduces the possibility of negative effects and unnecessary costs for the NHS.”
Preterm birth refers to the birth of a baby of less than 37 weeks gestational age, before the developing organs are mature enough to allow normal postnatal survival. The cause for preterm birth is in many situations elusive and unknown; many factors appear to be associated with the development of preterm birth, making the reduction of preterm birth a challenging proposition. Premature infants are at greater risk for short and long term complications, including disabilities and impediments in growth and mental development. Preterm birth is the major cause of neonatal mortality in developed countries.
Related Links:
King’s College London
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







